ID

18111

Beschreibung

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00225056

Link

https://clinicaltrials.gov/show/NCT00225056

Stichworte

Versionen (1)
  1. 20.10.16 20.10.16 -
Hochgeladen am

20. Oktober 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Metastatic Breast Cancer NCT00225056

Englisch

Eligibility Metastatic Breast Cancer NCT00225056

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have metastatic breast cancer
Beschreibung

Carcinoma breast stage IV

Datentyp

boolean

Alias
UMLS CUI [1]
C0278488
must have cytologically or pathologically confirmed invasive ductal or lobular carcinoma
Beschreibung

Invasive Ductal Breast Carcinoma | Carcinoma, Lobular

Datentyp

boolean

Alias
UMLS CUI [1]
C1134719
UMLS CUI [2]
C0206692
must have measurable or evaluable disease
Beschreibung

Measurable Disease | Evaluable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
ecog of 0-1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
patients may have received 0, 1. or 2 prior treatments for metastatic breast cancer
Beschreibung

Prior Therapy Quantity Carcinoma breast stage IV

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0278488
must have adequate organ function
Beschreibung

organ function

Datentyp

boolean

Alias
UMLS CUI [1]
C0678852
must be at least 19 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
peripheral neuropathy less than or equal to grade 1
Beschreibung

Peripheral Neuropathy | CTCAE Grades

Datentyp

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
must have voluntarily signed informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
patients with brain metastases are eligible provided that other measurable disease exists and brain lesions are controlled
Beschreibung

Metastatic malignant neoplasm to brain | Measurable Disease | Lesion of brain Controlled

Datentyp

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C1513041
UMLS CUI [3,1]
C0221505
UMLS CUI [3,2]
C2911690
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with other malignancies, except non melanoma of the skin, who have had any evidence of cancer within the last 5 years
Beschreibung

Malignant Neoplasms | Skin carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0699893
patients with psychiatric illness or other concurrent severe co-morbid medical condition that would preclude study completion
Beschreibung

Mental disorder Excludes Clinical Trial Completion | Comorbidity Severe Excludes Clinical Trial Completion

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0008976
UMLS CUI [1,4]
C0205197
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0332196
UMLS CUI [2,4]
C0008976
UMLS CUI [2,5]
C0205197
known uncontrolled existing coagulopathy
Beschreibung

Blood Coagulation Disorder Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005779
UMLS CUI [1,2]
C0205318
patients with a history of severe hypersensitivity reaction to docetaxel, medications formulated with polysorbate 80 or 5-fluorouracil
Beschreibung

severe allergy docetaxel | severe allergy Polysorbate 80 Formulation | severe allergy Fluorouracil Formulation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2945656
UMLS CUI [1,2]
C0246415
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C0032601
UMLS CUI [2,3]
C1705957
UMLS CUI [3,1]
C2945656
UMLS CUI [3,2]
C0016360
UMLS CUI [3,3]
C1705957
use of other investigational agents in the last 28 days
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
pregnant or lactating women
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who are known hiv positive
Beschreibung

HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
patients with life expectancy of less than 3 months
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
sexually active patients unwilling to practice reliable contraception during the study
Beschreibung

Sex Behavior Contraceptive methods Unwilling

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0036864
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Metastatic Breast Cancer NCT00225056

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Carcinoma breast stage IV
Item
must have metastatic breast cancer
boolean
C0278488 (UMLS CUI [1])
Invasive Ductal Breast Carcinoma | Carcinoma, Lobular
Item
must have cytologically or pathologically confirmed invasive ductal or lobular carcinoma
boolean
C1134719 (UMLS CUI [1])
C0206692 (UMLS CUI [2])
Measurable Disease | Evaluable Disease
Item
must have measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
ECOG performance status
Item
ecog of 0-1
boolean
C1520224 (UMLS CUI [1])
Prior Therapy Quantity Carcinoma breast stage IV
Item
patients may have received 0, 1. or 2 prior treatments for metastatic breast cancer
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,3])
organ function
Item
must have adequate organ function
boolean
C0678852 (UMLS CUI [1])
Age
Item
must be at least 19 years of age
boolean
C0001779 (UMLS CUI [1])
Peripheral Neuropathy | CTCAE Grades
Item
peripheral neuropathy less than or equal to grade 1
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Informed Consent
Item
must have voluntarily signed informed consent
boolean
C0021430 (UMLS CUI [1])
Metastatic malignant neoplasm to brain | Measurable Disease | Lesion of brain Controlled
Item
patients with brain metastases are eligible provided that other measurable disease exists and brain lesions are controlled
boolean
C0220650 (UMLS CUI [1])
C1513041 (UMLS CUI [2])
C0221505 (UMLS CUI [3,1])
C2911690 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Skin carcinoma
Item
patients with other malignancies, except non melanoma of the skin, who have had any evidence of cancer within the last 5 years
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
Mental disorder Excludes Clinical Trial Completion | Comorbidity Severe Excludes Clinical Trial Completion
Item
patients with psychiatric illness or other concurrent severe co-morbid medical condition that would preclude study completion
boolean
C0004936 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C0009488 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0205197 (UMLS CUI [2,5])
Blood Coagulation Disorder Uncontrolled
Item
known uncontrolled existing coagulopathy
boolean
C0005779 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
severe allergy docetaxel | severe allergy Polysorbate 80 Formulation | severe allergy Fluorouracil Formulation
Item
patients with a history of severe hypersensitivity reaction to docetaxel, medications formulated with polysorbate 80 or 5-fluorouracil
boolean
C2945656 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
C2945656 (UMLS CUI [2,1])
C0032601 (UMLS CUI [2,2])
C1705957 (UMLS CUI [2,3])
C2945656 (UMLS CUI [3,1])
C0016360 (UMLS CUI [3,2])
C1705957 (UMLS CUI [3,3])
Investigational New Drugs
Item
use of other investigational agents in the last 28 days
boolean
C0013230 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
patients who are known hiv positive
boolean
C0019699 (UMLS CUI [1])
Life Expectancy
Item
patients with life expectancy of less than 3 months
boolean
C0023671 (UMLS CUI [1])
Sex Behavior Contraceptive methods Unwilling
Item
sexually active patients unwilling to practice reliable contraception during the study
boolean
C0036864 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video